Interview: Ellson Chen, President & CEO, Vita Genomics, Taiwan
The President & CEO of Vita Genomics talks about the advantages that genomic testing offer both to sick and healthy patients, as well as the opportunities to catalogue the science…
Address: 7 Fl., No. 6, Sec. 1, Jung-Shing Road, Wugu Shiang, Taipei, Taiwan
Tel: (+886) 2-8976-9123
Web: http://www.vitagenomics.com/
Vita Genomics, founded in March 2001, has established its headquarter in Taiwan, a marketing office in California, USA, and a wholly owned subsidiary GeneCore in Shanghai, China. Vita Genomics has envisioned itself to be an important player in the healthcare industry by offering advanced and targeted molecular diagnostic products and services, providing more efficient and safer medical solutions, improving the drug development process, and lowering the overall healthcare cost through the pharmacogenomics approaches.Vita Genomics has already built up strong relationships with research institutions and medical organizations throughout Taiwan and China. We are constantly looking for pharmaceutical partners who can benefit from identifying patients for drug responsiveness prior to treatments, partners who would fund expanded pharmacogenomics studies that will enable us to validate the responsiveness of all significant genotypes, and partners who would co-develop DNA-based molecular diagnostic products. Vita Genomics is an active participant in modernizing Taiwan healthcare system. We are establishing the infrastructure needed to add the molecular profile information to the healthcare integrated circuit (IC) card. This is a first step in creating personalized medicine in the future. In addition, Vita Genomics can act as the conduit between the western world and China because we have already established a beachhead in Shanghai.
Vita Genomics follows the high standards of US FDA guidelines in collecting samples in conducting research and clinical studies.Vita Genomics concentrates on the elucidation of the genes and pathways involved in various diseases and on the drug responsiveness of patients in an attempt to improve the healthcare system.
The President & CEO of Vita Genomics talks about the advantages that genomic testing offer both to sick and healthy patients, as well as the opportunities to catalogue the science…
Yvonne Huang, VP of Aquavan, a company developing the most sophisticated high-tech green biotechnology platform for the extraction of plants, discusses their innovative technology and business scope while contributing to…
Chin Chun Lin, chairman of Taiwan Leader Biotech Corp., discusses the importance of herbal medicine for preventive healthcare, and shares valuable insights into Taiwan Leader Biotech Corp., a leading company…
Joshua Chang, CEO of RDD Lab, describes the scope of the company’s operations, the expansion of the firm’s capacities, and emerging trends in the CRO industry. Please begin by introducing…
Managing Director Chee Yaw Chek and Regional Customer Manager, Cindy Chan, discuss the importance of Taiwan for DHL, the customer-oriented service they nurture and their focus on ensuring Taiwanese companies…
Frank Douglas, CEO of the TheVax, discusses what he finds so inspiring about innovation in resource-constrained environments, and this Taiwanese biotech’s revolutionary SIT specific immunotherapy platform. The company was founded…
Joanna Yao, general manager of Taiwan & Hong Kong at Baxter, documents the company’s commitment to bring the most innovative renal diseases solutions and expertise to Taiwanese patients and physicians and…
Philips Healthcare Taiwan general manager, Jan Poon, talks about the innovative approach that Philips aims to implement in the local market; spanning from establishing a digital platform to working with…
Eric Tsao, founder of Synermore Biologics, talks about how a company employing 90 people can successfully operate internationally and efficiently progress with its biosimilar and innovative product development pipeline. He…
Ming-Kuei Jang, founder and CEO of Aprinoia, a very promising Taiwan-based company focused on the development of groundbreaking imaging tracers and therapeutics targeting tau-related neurodegenerative diseases, provides insights into the…
James Yang, Director of the Department of Oncology at National Taiwan University Hospital and Director of the Graduate Institute of Oncology at National Taiwan University, discusses the important role of…
Samuel Wang, Honorary President of the Taiwan Generics Pharmaceutical Association (TGPA) and President of the local distributor Weal-Chance Trading, provides insights into the recent international achievements of TGPA and the…
Jacob Lee, co-founder and CEO of DTCO, a Taiwan-based company focused on industrial blockchain services, documents the disruptive impact that the development of the blockchain technology in the healthcare and…
See our Cookie Privacy Policy Here